TCT 2016

Choice of Primary (or Co-primary) Endpoints: Efficacy, Safety, or Net Clinical Benefit in Superiority and Non-inferiority Trials

Roxana Mehran
44927

REGISTER for free or LOG IN to view this content

We Recommend